Multicenter collaborative study on the comprehensive collection and utilization of in-hospital real-world data (RWD) on cancer care.

Multicenter collaborative study on the comprehensive collection and utilization of in-hospital real-world data (RWD) on cancer care. - CONNECT2

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051605

Enrollment

12000

Registered

2023-07-14

Start date

2023-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing all cancer drug therapies (including postoperative adjuvant therapy and hormone therapy): Mainly solid tumors such as gastrointestinal cancer, lung cancer, breast cancer, gynecological tumors, urological tumors, malignant melanoma, cancer of unknown primary, and rare cancers are included. However, while it is desirable that all chemotherapy patients be selected in order to calculate statistical data within each institution, patient selection will be allowed to change according to the circumstances of each institution.

Exclusion criteria

Exclusion criteria: Patients who are deemed by the researcher to be inappropriate for participation in this study. For example, patients who are receiving medical treatment at other facilities with absolutely no known medical conditions.

Design outcomes

Primary

Measure	Time frame
The main objective of this project is to establish a highly universal medical information platform using CyberOncology by utilizing data from the hospital cancer registry.	—

Countries

Japan

Contacts

Public ContactShigemi Matsumoto

Kyoto University Hospital Clinical Oncology

motocame@kuhp.kyoto-u.ac.jp81-75-751-4349

Outcome results